Endocrine News Podcast | Podcast Guru

Overview

Episodes

Recent Episodes

ENP106: Reversing Bariatric Surgery

NOV 12, 2025

ENP106: Reversing Bariatric Surgery

Bariatric surgery is a procedure used to manage obesity and obesity-related conditions. While studies have shown that bariatric surgery leads to significant weight loss, are there cases where it may be important to consider reversing the procedure? What would such cases look like? How effectively can bariatric surgery be reversed? To help explore those questions, host Aaron Lohr talks with Katherine Hazen, MD, a second-year endocrine fellow at the University of Rochester Medical Center. She and colleagues presented an abstract at ENDO 2025 titled, “Going Backwards as a Means of Moving Forward: Severe Hypoglycemia After Bariatric Surgery.” Show notes are available at https://www.endocrine.org/podcast/enp106 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

12 MIN

ENP105: Tirzepatide and Menopause

OCT 29, 2025

ENP105: Tirzepatide and Menopause

In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

18 MIN

ENP104: Hidden Ingredients in Supplements

OCT 15, 2025

ENP104: Hidden Ingredients in Supplements

In the United States, the Food and Drug Administration doesn’t regulate supplements for safety and efficacy, so manufacturers don’t have to disclose their ingredients. We can’t always know for certain what’s in supplements we buy over the counter. Host Aaron Lohr talks with Meghana Pattipati, MD, an endocrine specialist at Ochsner Lafayette General Medical Center in Louisiana. Dr. Pattipati presented a study at ENDO 2025 in San Francisco titled, “Beware of the Hidden Ingredients and Supplement Use in Your Patients With Elevated Testosterone.” The presentation describes a case where a patient unknowingly ingested an ingredient that had a significant endocrine impact. Show notes are available at https://www.endocrine.org/podcast/enp104 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

10 MIN

ENP103: Type 1 Diabetes: Immunotherapies and Early Detection

OCT 1, 2025

ENP103: Type 1 Diabetes: Immunotherapies and Early Detection

Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1 diabetes with career development opportunities to build knowledge, practical skills, and a lasting network of colleagues. For this episode, host Aaron Lohr talks with Desmond Schatz, MD, medical director of the Diabetes Institute and director of the Clinical Research Center at the University of Florida. Dr. Schatz gave a talk at the fellows series program titled, “Immunotherapies for Type 1 Diabetes: Need for Early Detection and Screening.” This year’s fellows series program and this episode were made possible by the support of Abbott Diabetes Care, CeQur Corp., Dexcom Inc., Insulet Corp., Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation), Lilly USA, Mankind Pharma Limited, Medtronic Inc., Novo Nordisk Inc., and Vertex Pharmaceuticals Inc. Show notes are available at https://www.endocrine.org/podcast/enp103 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

23 MIN

ENP102: Insulin Delivery Systems (CME credit available)

SEP 17, 2025

ENP102: Insulin Delivery Systems (CME credit available)

In this episode, we cover type 1 diabetes and especially insulin delivery systems. Host Aaron Lohr talks with Grazia Aleppo, MD, from Northwestern University’s Feinberg School of Medicine and Diana Isaacs, PharmD, director of education and training in diabetes technology at the Cleveland Clinic. This episode is certified for up to 0.5 AMA PRA Category 1 credits and ABIM MOC points. However, claiming those points requires taking a pre-episode test. Then you must listen to the episode on the Endocrine Society’s Center for Learning website, followed by a post-episode test and evaluation. Please check the show notes for the appropriate link. This episode is supported by educational grants by MannKind Corp. and Insulet Corp. Show notes are available at https://www.endocrine.org/podcast/enp102 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

31 MIN